2025
SJR Q2
JCR Q2 · 2,2
142 matched articles
SCIE
Journal detail
Artificial Organs
- Publisher
- John Wiley and Sons Inc
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0160564X15251594
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,652
- Quartile Q2
- H-Index 92
- Cites/doc 2,36
- Docs (3y) 642
- Cites (3y) 1.519
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,2
- 5Y JIF 2,3
- JCI 0,51
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Bioengineering Q3
- Biomaterials Q3
- Biomedical Engineering Q2
- Medicine (miscellaneous) Q2
Areas
- Chemical Engineering
- Engineering
- Materials Science
- Medicine
WoS categories
- Engineering, Biomedical | Transplantation
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,652 | 2,2 | 2,3 | 0,51 | Q3 | 92 |
| 2024 | Q2 | Q2 | 0,631 | 2,3 | 2,3 | 0,57 | Q3 | 88 |
| 2023 | Q2 | Q3 | 0,651 | 2,2 | 2,3 | 0,57 | Q3 | 88 |
| 2022 | Q2 | Q3 | 0,522 | 2,4 | 2,4 | 0,61 | Q3 | 88 |
| 2021 | Q3 | Q3 | 0,5 | 2,7 | 2,4 | 0,66 | Q2 | 88 |
| 2020 | Q2 | Q3 | 0,684 | 3,1 | 2,7 | 0,84 | Q2 | 88 |
| 2019 | Q2 | Q3 | 0,806 | 2,3 | 2 | 0,78 | Q2 | 88 |
| 2018 | — | Q2 | — | 2,4 | 2,1 | 0,82 | Q2 | — |
| 2017 | Q2 | Q2 | 0,736 | 2,1 | 1,9 | 0,84 | Q2 | 88 |
| 2016 | Q2 | Q2 | 0,803 | 2,4 | 1,8 | — | — | 88 |
| 2015 | Q2 | Q2 | 0,875 | 2 | 1,7 | — | — | 88 |
| 2014 | Q2 | Q2 | 0,793 | 2 | 1,7 | — | — | 88 |
| 2013 | Q2 | Q2 | 0,839 | 1,9 | 1,7 | — | — | 88 |
| 2012 | Q1 | Q2 | 0,896 | 2 | 1,8 | — | — | 88 |
| 2011 | Q2 | Q2 | 0,761 | 2 | 1,9 | — | — | 88 |
| 2010 | Q2 | Q2 | 0,656 | 1,7 | 1,8 | — | — | 88 |
| 2009 | — | Q2 | — | 1,8 | 1,9 | — | — | — |
| 2008 | — | Q2 | — | 2,1 | 1,8 | — | — | — |
| 2007 | — | Q2 | — | 1,8 | 1,5 | — | — | — |
| 2006 | — | Q2 | — | 1,9 | — | — | — | — |
| 2005 | — | Q1 | — | 1,9 | — | — | — | — |
| 2004 | — | Q2 | — | 1,6 | — | — | — | — |
| 2003 | — | Q2 | — | 1,3 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 0,9 | — | — | — | — |
| 2000 | — | Q3 | — | 1 | — | — | — | — |
| 1999 | — | Q2 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 89/130 |
| 2025 | TRANSPLANTATION | SCIE | Q2 | Q3 | 14/30 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 81/124 |
| 2024 | TRANSPLANTATION | SCIE | Q2 | Q3 | 13/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 82/123 |
| 2023 | TRANSPLANTATION | SCIE | Q3 | Q3 | 16/31 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 67/96 |
| 2022 | TRANSPLANTATION | SCIE | Q3 | Q3 | 16/26 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 69/98 |
| 2021 | TRANSPLANTATION | SCIE | Q3 | Q2 | 16/25 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 47/89 |
| 2020 | TRANSPLANTATION | SCIE | Q3 | Q2 | 13/25 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 51/87 |
| 2019 | TRANSPLANTATION | SCIE | Q3 | Q2 | 14/24 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 37/80 |
| 2018 | TRANSPLANTATION | SCIE | Q3 | Q2 | 15/25 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 35/78 |
| 2017 | TRANSPLANTATION | SCIE | Q3 | Q2 | 14/25 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 28/77 |
| 2016 | TRANSPLANTATION | SCIE | Q3 | — | 14/25 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 33/76 |
| 2015 | TRANSPLANTATION | SCIE | Q3 | — | 15/25 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 31/76 |
| 2014 | TRANSPLANTATION | SCIE | Q3 | — | 15/25 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 30/76 |
| 2013 | TRANSPLANTATION | SCIE | Q3 | — | 14/26 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 31/79 |
| 2012 | TRANSPLANTATION | SCIE | Q3 | — | 15/26 |
| 2011 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 31/72 |
| 2011 | TRANSPLANTATION | SCIE | Q3 | — | 14/24 |
| 2010 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 33/70 |
| 2010 | TRANSPLANTATION | SCIE | Q3 | — | 17/25 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 27/59 |
| 2009 | TRANSPLANTATION | SCIE | Q3 | — | 15/24 |
| 2008 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 19/52 |
| 2008 | TRANSPLANTATION | SCIE | Q3 | — | 13/21 |
| 2007 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 15/44 |
| 2007 | TRANSPLANTATION | SCIE | Q3 | — | 15/21 |
| 2006 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 14/42 |
| 2006 | TRANSPLANTATION | SCIE | Q3 | — | 14/19 |
| 2005 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 10/41 |
| 2005 | TRANSPLANTATION | SCIE | Q3 | — | 13/20 |
| 2004 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 14/42 |
| 2003 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 15/42 |
| 2002 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 25/40 |
| 2001 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 22/39 |
| 2000 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 21/41 |
| 1999 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 21/43 |
| 1998 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 29/45 |
| 1997 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 21/41 |